The Paradox of Obesity in Patients with Heart Failure

Authors

  • Jill A. Hall MS,

    Corresponding author
      Contact Jill Hall by e-mail at ldjhall4@hotmail.com
    Search for more papers by this author
    • 1

      Authors
      Jill A. Hall, MS, Thomas K. French, MS, Kismet D. Rasmusson, MS, Jill C. Vesty, MS, Colleen A. Roberts, MS, Holly L. Rimmasch, MS, A. G. Kfoury, MD, and Dale G. Renlund, MD, are members of the Heart Failure Prevention and Treatment Program team in Salt Lake City, Utah, at LDS Hospital.

  • Thomas K. French MS,

    Search for more papers by this author
    • 1

      Authors
      Jill A. Hall, MS, Thomas K. French, MS, Kismet D. Rasmusson, MS, Jill C. Vesty, MS, Colleen A. Roberts, MS, Holly L. Rimmasch, MS, A. G. Kfoury, MD, and Dale G. Renlund, MD, are members of the Heart Failure Prevention and Treatment Program team in Salt Lake City, Utah, at LDS Hospital.

  • Kismet D. Rasmusson MS,

    Search for more papers by this author
    • 1

      Authors
      Jill A. Hall, MS, Thomas K. French, MS, Kismet D. Rasmusson, MS, Jill C. Vesty, MS, Colleen A. Roberts, MS, Holly L. Rimmasch, MS, A. G. Kfoury, MD, and Dale G. Renlund, MD, are members of the Heart Failure Prevention and Treatment Program team in Salt Lake City, Utah, at LDS Hospital.

  • Jill C. Vesty MS,

    Search for more papers by this author
    • 1

      Authors
      Jill A. Hall, MS, Thomas K. French, MS, Kismet D. Rasmusson, MS, Jill C. Vesty, MS, Colleen A. Roberts, MS, Holly L. Rimmasch, MS, A. G. Kfoury, MD, and Dale G. Renlund, MD, are members of the Heart Failure Prevention and Treatment Program team in Salt Lake City, Utah, at LDS Hospital.

  • Colleen A. Roberts MS,

    Search for more papers by this author
    • 1

      Authors
      Jill A. Hall, MS, Thomas K. French, MS, Kismet D. Rasmusson, MS, Jill C. Vesty, MS, Colleen A. Roberts, MS, Holly L. Rimmasch, MS, A. G. Kfoury, MD, and Dale G. Renlund, MD, are members of the Heart Failure Prevention and Treatment Program team in Salt Lake City, Utah, at LDS Hospital.

  • Holly L. Rimmasch MS,

    Search for more papers by this author
    • 1

      Authors
      Jill A. Hall, MS, Thomas K. French, MS, Kismet D. Rasmusson, MS, Jill C. Vesty, MS, Colleen A. Roberts, MS, Holly L. Rimmasch, MS, A. G. Kfoury, MD, and Dale G. Renlund, MD, are members of the Heart Failure Prevention and Treatment Program team in Salt Lake City, Utah, at LDS Hospital.

  • A. G. Kfoury MD,

    Search for more papers by this author
    • 1

      Authors
      Jill A. Hall, MS, Thomas K. French, MS, Kismet D. Rasmusson, MS, Jill C. Vesty, MS, Colleen A. Roberts, MS, Holly L. Rimmasch, MS, A. G. Kfoury, MD, and Dale G. Renlund, MD, are members of the Heart Failure Prevention and Treatment Program team in Salt Lake City, Utah, at LDS Hospital.

  • Dale G. Renlund MD

    Search for more papers by this author
    • 1

      Authors
      Jill A. Hall, MS, Thomas K. French, MS, Kismet D. Rasmusson, MS, Jill C. Vesty, MS, Colleen A. Roberts, MS, Holly L. Rimmasch, MS, A. G. Kfoury, MD, and Dale G. Renlund, MD, are members of the Heart Failure Prevention and Treatment Program team in Salt Lake City, Utah, at LDS Hospital.


Contact Jill Hall by e-mail at ldjhall4@hotmail.com

Abstract

Purpose

Heart failure (HF) patients often have comorbid conditions that confound management and adversely affect prognosis. The purpose of this study was to determine whether the obesity paradox is also present in hospitalized HF patients in an integrated healthcare system.

Data sources

A cohort of 2707 patients with a primary diagnosis of HF was identified within an integrated, 20-hospital healthcare system. Patients were identified by ICD-9 codes or a left ventricular ejection fraction ≤40% dating back to 1995. Body mass index (BMI) was calculated using the first measured height and weight when hospitalized with HF. Survival rates were calculated using Kaplan Meier estimation. Hazard ratios for 3-year mortality with 95% confidence intervals were assessed using Cox regression, controlling for age, gender, and severity of illness at time of diagnosis.

Conclusions

Three-year survival rates paradoxically improved for patients with increasing BMI. Survival rates for the larger three BMI quartiles were significantly better than for the lowest quartile after adjusting for severity of illness, age, and gender.

Implications for practice

While obesity increases the risk of developing HF approximately twofold, reports involving stable outpatients suggest that obesity is associated with improved survival after the development of HF. This finding is paradoxical because obesity increases the risk and worsens the prognosis of other cardiovascular diseases.

Ancillary